Clinical Trial Update: The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD) [EARLY_Phase 1]

View source ↗

Summary

The early-phase trial evaluating tasimelteon for REM sleep behavior disorder has been terminated. No results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rem Sleep Behavior Disorder

Drugs mentioned

• Tasimelteon (tasimelteon)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: REM Behavior Disorder | EARLY_Phase 1 | Status: TERMINATED